Pingfei Fang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Myasthenia Gravis

Estrogen Receptor

Top Venues

The FEBS journal

Expert opinion on investigational drugs

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Xiding Yang, Ronghua Zhu, Jing Zhang, Zaihua Hou, Lingfeng Yang, Xiao Fan, Qiangyong Yan, Jingjing Li, Zhiguang Zhou, Pingfei Fang
First-in-human phase I studies of YJ001 spray applied to local skin in healthy subjects and patients with diabetic neuropathic pain. Expert opinion on investigational drugs (2023)
Pingfei Fang, Changwei Yu, Jian Liu, Gongying Deng, Min Zhang
Study on the Potential Mechanism of Semen Strychni against Myasthenia Gravis Based on Network Pharmacology and Molecular Docking with Experimental Verification. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Min Zhang, Xiaoyu Duan, Lu Wang, Jing Wen, Pingfei Fang
Deregulation of HSF1-mediated endoplasmic reticulum unfolded protein response promotes cisplatin resistance in lung cancer cells. The FEBS journal (2022)
Min Zhang, Xiaoyu Duan, Lu Wang, Jing Wen, Pingfei Fang
Deregulation of HSF1-mediated endoplasmic reticulum unfolded protein response promotes cisplatin resistance in lung cancer cells. The FEBS journal (2022)
Yalan Xiang, Chao Wang, Jing Wen, Min Zhang, Xiaoyu Duan, Lu Wang, Miao Yan, Huan-De Li, Pingfei Fang
Investigation of the detoxification effect of licorice on Semen Strychni -induced acute toxicity in rats using a HPLC-Q-TOF/MS-based metabolomics approach. RSC advances 10 (72) (2020)